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Navigation processes selectively mediated by functio al activity of the entorhinal cortex (EC) may be 
a marker of preclinical Alzheimer’s disease (AD). Here, we tested if a short path integration paradigm 
can detect the strongest genetic-risk phenotype of AD in large sample of APOE genotyped 
individuals. We also examined the associations betwe n APOE mediated navigation process, 
subjective cognitive decline and rest-stating network c nnectivity. Navigation discrepancies classified 
77% the APOE genotyped cohort into their respective low-risk ε3ε3 and high-risk ε3ε4 categories. 
When connectivity strength between entorhinal and the posterior cingulate cortices (also a functional 
correlate of strongest APOE-dependant behavioural chara teristics) was considered, this classification 
accuracy increased to 85%. Our findings present a whole picture of at-genetic-risk AD, including 
select impairment in path integration, self-report c gnitive decline, and altered network activity that is 
reminiscent of the pathological spread of preclinical AD disease. These findings may have important 
implications for the early detection of AD. 
 







Late-onset Alzheimer’s disease (AD) is one of the biggest burdens to modern society with up to 50 
million people living with the disease worldwide and o curative therapies to treat the underlying 
cause of the disease pathology (Nichols et al., 2019). As current evidence shows that gold standard 
episodic memory tests fail to capture the first symptomatic manifestation of AD (Coughlan et al., 
2018b; Jessen et al., 2014; Zimmermann et al., 2019; Zimmermann and Butler, 2018), alternative 
diagnostic tools are urgently required in order advance cognitive diagnostics for incipient AD. Spatial 
orientation is a promising preclinical marker and is already established as a critical diagnostic tool in 
the late clinical and early prodromal stages of disease (Hort et al., 2014, 2007; Howett et al., 2019; 
Laczó et al., 2009; Lester et al., 2017; Mokrisova et l., 2016; Pai and Jacobs, 2004; Serino and Riva,
2013; Tu et al., 2015; Vlček, K., & Laczó, 2014). For example, spatial navigation tasks, such as the 
Virtual Supermarket Test (VST) (Tu et al., 2015) distinguish AD from other dementias and have been 
implemented in high-profile clinical trials due to their high sensitivity and specificity of AD 
pathophysiology (Ritchie et al., 2016; Ritchie and Ritchie, 2012).  
AD patients typically sustain widespread navigation deficits, with severe difficulty storing 
and retrieving an allocentric representation (or a cognitive map) of the environment (DeIpolyi et al.,
2007; Jheng and Pai, 2009; Serino et al., 2015). This is due to significant neuronal loss in the 
hippocampus where place cells are located and mediate the human and rodent cognitive map (Bird 
and Burgess, 2008; O’Keefe, John & Nadel, 1978). AD patients also experience loss of egocentric 
self-reference navigation strategy due to abnormal structural and cellular changes in the retrosplenia 
cortex, the posterior cingulate cortex (PCC) and parietal cortex of the AD brain (Mokrisova et al., 
2016; Pai and Yang, 2013; Pengas et al., 2010; Serino t al., 2015). More recent developments in 
immersive virtual reality path integration (or self-motion) tests show that even individuals in the 
earlier stage of the disease spectrum characterised by ‘mild cognitive impairment’, suffer significant 
navigational errors during path integration, which has been directly associated with volumetric loss in 
the entorhinal cortex (Howett et al., 2019). This is important, because in the earlier asymptomatic 
stage of disease known as ‘‘preclinical AD’’, neuropathology is relatively localised to the EC, 
suggesting that path integration tests may be sensitive to the subtle AD related preclinical changes in 
navigation performance (Jack et al., 2018; Reisa A. Sperling, Paul S. Aisen, Laurel A. Beckett, David 
A. Bennet, 2011).           
 On a cellular level, reduced grid cell representations in the entorhinal cortex correlate path 
integration deficits in healthy at-genetic-risk apoli protein E (APOE) ε4 carriers, who are three to 
four times more likely to develop AD compared to non ε4 carriers (Corder et al., 1993; Kunz et al., 
2015b). The same pattern of navigational discrepancies was replicated on the Sea Hero Quest game, 
which was then shown to discriminated ε4 carriers from non-carriers with a classification accuracy of 
72%, although no MRI data was available to pinpoint the neural changes that gave rise to ε4-related 
   
path integration deficits (Coughlan et al., 2019). Adding further support to the hypothesis that EC 
mediated navigation changes may represent an early cognitive marker for preclinical AD, transgenic 
rodent models show spatial memory deficits measured on the Morris water maze occur just before 
mature tau tangles spread beyond the entorhinal cortex (Fu et al., 2017).    
 While the field is largely focused on EC-mediate navigation impairments for the early 
detection of preclinical AD, functional connectivity (FC) changes also occur other brain regions such 
as the PCC and the precuneus in the preclinical stage  of disease (Badhwar et al., 2017; Hanseeuw et 
al., 2017; Minoshima et al., 1997; Pengas et al., 2010; Reisa A. Sperling, Paul S. Aisen, Laurel A. 
Beckett, David A. Bennet, 2011). These more partial based changes are understood to be functional 
responses to early AD pathology within medial temporal lobe  (Badhwar et al., 2017; Braak and Del 
Tredici, 2015; Chase, 2014). Despite this, resting-state FC within the spatial network that connects the 
EC, the PCC and the precuneus have not yet been examined in the context of navigation impairments 
in preclinical AD. To address this gap, we examined avigation performance and resting-state FC in 
APOE genotyped ε4 carriers and non-carriers. We first tested four major navigation process using a 
short path integration paradigm called the VST, and then examined the relationship between 
navigation performance and FC in a sub-set of the study sample; with a specific focus on the 
connectivity strength between the EC, the hippocampus, the PCC and the precuneus. We hypothesised 
that if ε4 navigation impairment was captured on the path integration test, impairment would correlate 
with reduced edge strength of the EC in the proposed neural network. As an additional measure, we 
assessed if subjective cognitive impairment, often co sidered a first symptomatic manifestation of 
disease (Jessen et al., 2014), accompanies navigation impairment and/or altered connectivity strength 
in the neural network. 
 




 We recruited 150 participants between 50 and 75 years to participate in a research study at the 
University of East Anglia. Written consent was obtained from all participants and ethical approval 
was obtained from Faculty of Medicine and Health Scien es Ethics Committee at the University of 
East Anglia, Reference FMH/2016/2017–11. All 150 participants were pre-screened over the phone 
for exclusion criteria including psychiatric or neurological disease, substance dependence disorder 
and clinical depression and/or anxiety. Individuals with medicated cholesterol or blood pressure were 
included in the study, but medication intake was reco ded to ensure there were not differences 
between genetic groups. Moreover, only participants with normal or corrected-to-normal vision were 
retained due to the nature of the VR task. Family history of AD was not included in the analysis, as 
there was considerable uncertainty when participants were asked the number of parents (0, 1 or 2) 
   
with dementia and in particular the type of dementia. Finally, saliva samples were collected via buccal 
swab from participants who passed this screening and APOE genotype status was determined. Please 
refer to (Coughlan et al., 2019), for a description on the APOE genotyping method used on the study 
cohort. 
All identified APOE ε4 allele carriers who represent 25% of the population (23% APOE ε3ε4, 2% 
APOE ε4ε4; Corbo and Scacchi, 1999; Liu et al., 2013), were matched with a subset of the ε3ε3 
carriers, which is the population wild-type genotype (60%) for age and sex (see Table S1 for group 
background characteristics). Homozygous APOE-ε4 carriers (2% of the population) and APOE ε2 
carriers (13% of the UK population) were excluded. This yielded a final sample size of 64 (including 
32 ε3ε3 carriers and 32 ε3ε4 carriers) all of whom underwent cognitive testing. Mean age of the ε3ε3 
group and the ε3ε4 group was 62.28 ± 6.04 and 62.19 ± 6.64 respectively. Twenty ε3ε3 carriers and 
20 ε3ε4 carriers also underwent structural and functional MRI. One ε3ε3 participant did not complete 
the scan due to distress and their data were excluded from the analysis. Two additional participants 
(two ε3ε4 carriers) who completed the MRI stage of the study were removed due to a software error 
that led to severe artefacts in the resting-state fMRI data. After these exclusions, MRI data on 37 out 
of 64 (58%) sample size was used for analysis, reaching an acceptable fMRI sample size (Pajula and 
Tohka, 2016). Among the genetic groups who underwent n uroimaging the mean age of the e3e3 was 
63.21 ± 5.23 (including 11 male 8 females) and the mean age of the e3e4 group was 62.01 ± 6.92 
(including 8 male 10 females). Please see SI Figure 1 for a summary of the sample size breakdown 
across study stages. 
 
 
2.2 Paradigm overview 
 
The VST is a sensitive and specific measure for differentiating AD from other dementia types 
(Coughlan et al., 2018a; Tu et al., 2017, 2015) . It includes a path integration test and measures i) 
egocentric orientation; ii) short-term spatial memory; iii) heading direction and iv) central (vs 
boundary) based navigation preferences. In brief, an iP d 9.7 (Apple Inc,) is used to show participants 
7-14-second video clips of a moving shopping trolley in a virtual reality supermarket from the first-
person perspective (Figure 1 A-C). The absence of landmarks in the supermarket aims to ensure the 
test taps into EC-grid cell dependent strategies rathe  than striatal-mediated landmark-based 
navigation. Once the video clip stops, participants i dicate in real-life the direction of their starting 
point (egocentric orientation; Figure 1 D). In a second step, participants indicate their finishing 
location (short-term spatial memory; Figure 1 E) and heading direction on a VST map (grey arrow). 
We extended our VST paradigm to a fourth spatial measure based on evidence of an entorhinal-
mediated bias or tendency to navigate towards enviro mental boundaries during path integration in at-
genetic-risk AD. Specifically, we recorded the number of responses in the centre and boundary space 
   
of the supermarket map to produce a central navigation preference measure (Figure 1 F; see 
supplementary text for more information on the creation of the central navigation preference 
measure). 
 
2.3 Neuropsychological assessment 
 
The aim of the current study was to assess the impact of APOE genotype independent of, and prior to, 
AD symptomology. The Addenbrooke’s cognitive examination (ACE-III) was used to detect 
cognitive impairment associated with AD (Matias-Guiu et al., 2017). Only participants who scored in 
the normal range (ACE-III>88) were retained. The Rey–Osterrieth Complex Figure Test (RCFT; with 
3-min delayed recall) and the Four Mountains test were used as secondary screening measures to 
assess any non-verbal episodic memory or spatial memory differences between genetic groups (Chan 
et al., 2016; Shin et al., 2006). 
 
2.4 Subjective cognitive change assessment 
 
Subjective cognitive decline was evaluated to identify decline in self-perceived episodic memory and 
executive function over the 5 years before testing. I  prior work, subjective memory concerns have 
been identified in asymptomatic familial AD carriers, and concerns are seemly predictive of faster 
rates of memory decline (Samieri et al., 2014; Weston et al., 2018). The presence of subjective 
cognitive concerns is also related to abnormal changes in Aβ and tau biomarkers in APOE ε4 carriers 
(Risacher et al., 2015) and is thus considered important for early detection. Here, we measure this 
using the Cognitive Change Index (CCI; Rattanabannakit et al., 2016) that consists of 20 questions 
relating to the perceived decline. Responses are given on a five-point scale ranging from 1 = “normal 
ability” to 5 = “severe problem”, with higher scores indicating larger concerns. 
 
2.5 Functional MRI acquisition  
 
Structural and functional MRI data for 40 participants (20 ε3ε3 carriers and 20 ε3ε4 carriers) was 
obtained using a 3 tesla Discovery 750w widebore system (GE Healthcare, Milwaukee, WI, USA) 
with a 12-channel phased-array head coil for signal reception. After localisers,  T1-weighted (T1w) 
structural data was acquired using a whole-head 3D inversion-recovery fast spoiled gradient recalled 
echo (IR-FSPGR) sequence with the following parameters: repetition time = 7.7 ms; echo time = 3.1 
ms; inversion time = 400 ms; field-of-view = 256 mm; acquired matrix = 256 × 256; 200 sagittal 
sections of 1 mm thickness ; flip angle = 11°; and  ASSET acceleration factor of 2 in the phase-
encoding direction. Furthermore, a 3D T2-weighted fluid attenuated inversion recovery (T2w FLAIR) 
sequence was prescribed as follows: repetition time = 4,800 ms; echo time = 129 ms; inversion time = 
   
1,462 ms; field-of-view = 256 mm; acquired matrix = 256 × 256; 182 sagittal sections of 1 mm 
thickness ; flip angle = 90°; an ARC acceleration factor of 2 in the phase-encoding direction; and a 
‘HyperSense’ compressed sensing subsampling factor of 2.  
Functional images were acquired using a gradient echo ho-planar imaging sequence with the 
following parameters: repetition time = 3,500 ms; echo time = 30 ms; field-of-view = 240 mm; 
acquired matrix = 96 × 96, reconstructed to 128 × 128; 42 axial slices of 3.5 mm thickness; flip angle 
= 80°; and an ASSET acceleration factor of 2 in the p ase-encoding direction. The fMRI time series 
consisted of 200 images, and the total acquisition time was 11 minutes 54 seconds. During functional 
runs, subjects were required to not fall asleep and keep alert with their eyes closed for 10 min. To 
avoid the effect of participants employing specific strategies to maintain alertness (e.g. reminiscing or 
counting scan number), participants were instructed not to think about anything in particular. Prior to 
analyses, all participant scans were visually inspected for significant head movements and artefacts. 
Please see supplementary information (SI) for pre-processing structural and functional MR images.  
 
2.6 Statistical analysis  
 
Statistical analysis was performed using SPSS (v25.0), FSL (v6.0.0), MATLAB (MathWorks, 
R2018a), Octave (v4.4.1) and FreeSurfer for SI ROI morphometry analysis (v11.4.2).  
An ANCOVA adjusted for age and sex was used to examine APOE differences on the 
neuropsychological assessment. Pearson’s Chi square assessed differences on secondary 
characteristics between APOE groups including, marital status, educational attainment, occupation, 
and medically controlled cholesterol and blood pressure. All group comparisons on VST spatial 
performance and CCI were conducted using the same gen ral linear model including APOE, as main 
predictor of interest, Despite recruiting age and sex matched groups, we included age and sex as 
covariates given their strong effect on brain function and volume, navigation performance and 
vulnerability to AD (Coutrot et al., 2018; Ferretti e  al., 2018; Lester et al., 2017; Neu et al., 2017). 
We thus aimed to exclude any variance in the outcome measures that could be explained by these 
variables in order to determine an unbiased effect of APOE. Associations between VST and CCI 
measured were tested using partial Pearson correlation in SPSS adjusted for age and sex.  
Voxel-based morphometry (VBM) was conducted on whole-brain T1weighed scans, using the 
VBM toolbox in FSL to confirm no grey matter structral differences between the genetic groups 
(Douaud et al., 2007; Good et al., 2001). FreeSurfer was used to segment and parcellate whole-brain 
T1-weighed images and generate volumetric measures fo anatomical ROIs. FC between pairs of the 
six ROIs were analysed by extracting the first eigenvector from the BOLD timeseries for each ROI, 
and each single participant, using ‘fslmeants’. If two brain regions show similarities in their BOLD 
timeseries, they are functionally connected (Haneef et al., 2014). A total of 195 of the 200 functional 
timepoints for each ROI were retained for analysis. All functional network modelling with timecourse 
   
data was carried out using FSLNets v0.6 so that the functional connectivity results were family wise 
error (FWE) corrected for multiple comparisons. After computing the subject-specific 6nodes × 6nodes 
connectivity matrix, direct and ridge regularised partial correlations were calculated between all pairs 
of ROIs, where direct correlations are correlations between two ROIs, controlling for the effect of all 
other ROI-ROI correlations. The resulting Pearson crrelation coefficients were converted to z scores 
via Fisher’s transformation to test the significance of any functional connectivity differences between 
the genetic groups (Smith et al., 2011). All functional analyses were carried out in MNI standard 
space. Significance testing for functional MRI differences was conducted using voxel-wise general 
linear modelling by employing the threshold-free cluster enhancement (TFCE) method (Smith and 
Nichols, 2009). The TFCE produces voxel-wise P-values via 5,000 permutation-based non-parametric 
testing (Nichols and Holmes, 2001). All scripts ranin the aforementioned software packages are 
available from authors. 
 
3. Results  
 
3.1 Neuropsychological assessment  
 
As expected, no differences between the two genetic groups evident for on the neuropsychological 
assessment (Table 1) or on secondary characteristics ( ee SI Table 1), which confirmed that the 
impact of APOE genotype prior to clinically detectable MCI/AD symptomology could be measured. 
 
3.2 Spatial navigation assessment  
 
Heading direction (F=.799., P = .375, SI Figure 1B) and short-term spatial memory (F=.014, P = 
.907) were unaffected by genotype and thus, we concluded group differences on other VST sub-
measures could not be accounted for by differences in short-term spatial memory ability. Egocentric 
orientation was significantly different between genetic groups, with ε3ε4 participants making fewer 
correct responses, compared with ε3ε3 participants (F = 4.21; P = .042). Central navigation 
preference was also significantly different between the groups (F = 12.45, P < 0.005), with ε3ε3 
participants favouring more central responses and ε3ε4 carriers favouring more boundary responses 
(see Figure 2A-C; Table 2 for mean values). 
 
3.3 Subjective cognitive change assessment  
 
Next, we examined the significance of any differences on self-reported cognitive decline (within the 
last 5 years) between the genetic groups. ε3ε3 participants reported less decline on both episodic 
memory (F=5.24 p=.026) and executive function (F=5.92 P=.018; SI Figure. 1 D-E). Thus, we then 
   
sought to test associations between navigation performance on the VST and CCI scores. Heading 
orientation, short-term spatial memory and central navigation preference were not significantly 
associated with CCI scores. Egocentric orientation was associated with self-reported decline in 
executive function (r=-.347, p=.008; i.e. better egocentric performance is related to less subjective 
decline). 
 
3.4 Volumetric and/or functional connectivity  
 
Having clarified the behavioural characteristics of ε4-related navigation impairment on the VST, we 
sought to investigate 1) the statistical significance of volumetric differences and/or functional 
connectivity changes between genetic groups and 2) if a neural correlate(s) for e4-related navigation 
impairment on the VST could be identified. No significant grey matter volumetric differences 
between the groups (p = 0.18) were present. As a secondary measure, we tested the mean ROI 
network volumes (right/left hippocampus, right/left EC, PCC, Precuneus; see Figure 3A). No 
difference was found between the genetic groups (see SI Table 2 for mean ROI volumetric values 
between groups).  
 
Next, we examined FC between the ROIs to investigate po ential differences in connectivity strength 
between the genetic groups. Full and partial correlations were tested in FSLNets to correct for 
multiple comparisons, meaning only effects withstanding familywise error correction were reported as 
significant. Right EC and PCC FC was significantly lower in ε3ε4s relative to ε3ε3s (t=-2.608; 
uncorrected p=.01; corrected p=.03; 95%CI [-.426 -.053]; rs = .171, F=6.80, p=098), even after 
multiple comparison correction (PFWE = 0.027) at a partial level (i.e. not controlling forall other ROI-
ROI correlations). When controlling for all other ROI-ROI correlations (i.e. direct), the effect of 
APOE on right EC and PCC FC was significant at the uncorrected (P =0.017), but not at the corrected 
level (PFWE = 0.157). Trend differences in the opposite direction were observed between the 
precuneus and the PCC, with higher FC between theseregions in ε3ε4s compared to ε3ε3s (t=-2.225; 
uncorrected p=.03; corrected p=.06; 95%CI=[.009 .214]; ; rs = .228; P=035; Figure 3B for group 
comparison connectivity matrix). Finally, to localise PCC connectivity differences in the EC, we used 
dual regression to test PCC connectivity in the whole brain which revealed reduced connectivity was 
localised to the dorsomedial subregion of the right EC (MNI [x y z] coordinates, [24 -6 -32], tfce 
corrected P<0.05). Please see SI for the independent ε3ε3 and ε3ε4 connectivity matrices (SI Figure 
2). 
 
3.5 Functional connectivity and ε4 sensitive navigation processes.  
 
   
Having determined altered FC changes in the EC, PCCand precuneus between genetic groups, FC 
strength between each ROI pair was correlated the ε4-sensitive VST measures: egocentric orientation 
and central navigation preference. We expected that right-EC-PCC FC would correlate with at least 
one of the ε4-related behavioural characteristics. Right EC-PCC connectivity strength negatively 
correlated with central navigation preference (t=2.45, r=0.40, corrected PFWE =0.018) when direct (but 
not partial) correlations were used as a connectivity metric (Figure 3C). No correlate in the pre-
defined neural network for egocentric orientation was present. See SI for investigations on the 
functional neural correlates of the two additional VST measures. 
 
3.6 ε4-related functional connectivity and subjective cognitive decline 
 
Based on the ε4-related changes on self-reported cognitive declin, we then measured associations 
between EC-PCC FC with CCI scores. Connectivity strength between the right EC – PCC was
negatively correlated with subjective decline in episodic memory (t=-3.01, r=-.407, uncorrected 
P=.005, corrected PFWE=.017), but not with executive function (t = -2.02, r=-.341, uncorrected 
P=.052; Figure 3C).  
 
3.7 Classifying genetic groups based on VST and functional connectivity 
 
Although no neuro-functional correlate was identified for egocentric orientation or subjective 
executive function decline, the neuro-functional correlate of the two strongest e4 behavioural 
characteristics, central navigation preference and subjective episodic memory decline, overlapped. 
Thus, as a final step, we tested its clinical utility to classify at-genetic-risk AD. In the first instance, 
we did not include functional connectivity and subjective decline measures, as our primary aim was to 
test the diagnostic value of the VST for at-genetic-risk AD. Thus, the first logistic regression model 
entered aimed to classify ε3ε3 and ε3ε4 carriers based on central navigation preference ad egocentric 
orientation measure. This model was statistically significant (X2(2) 20.22, P < .001) and correctly 
classified 77.4% of the overall cohort (n=64). The percentage of classification was equal across ε4 
carriers and non-carriers (Figure 4 A). We then included the right EC –PCC measure to weigh the 
utility of including a neuro-functional correlate to improve the classification. Note the sample size 
dropped to 37 with the inclusion of MRI measures. A expected, the regression model was 
statistically significant, x2(3) 16.85, P < .001) and classification accuracy shifted from 77.4% to 85%. 
Specifically, the model correctly classified 82.3% of ε3ε3 carriers and 88.3% of the ε3ε4 carriers 
(Figure 4 A). The log odds units presented are the values for the logistic regression equation for 
predicting APOE status from the three independent variables. The prediction equation is: 
 
   
log  − 	 = 6.86 − 7.33 ∗ 			 − .28 ∗ 	 −
1.47 ∗ [ℎ	#$ − %$$]) 
 
ROC curves were computed with these three predictors. Area under the curve (AUC) values indicated 
right EC-PCC connectivity (AUC .702, SE .092) and the egocentric task (AUC .659, SE .098) had a 
similar level of diagnostic accuracy. Central navigtion preference showed the best accuracy of the 




APOE ε4 is the strongest genetic risk factor for late-onset AD. Yet, whether preclinical stage 
cognitive changes are detectable on a short clinicaly feasible task is unknown. Our results show that
the classification accuracy of the path integration est, coupled with intrinsic FC strength between the 
EC - PCC reaches 85% providing a springboard for the development of a simple multimodal 
framework for at-genetic-risk AD. Extending the existing literature, we show that i) navigation 
discrepancies following path integration co-exist with subjective cognitive concern in adults at-
genetic risk of AD and ii) reduced network connectivity between the right EC and the PCC correlate 
with navigation discrepancies and subjective episodic memory concerns which characterise the at-
genetic-risk behavioural phenotype. 
Significant differences between the APOE genetic groups were found in two out of four of 
the VST spatial sub-measures: Egocentric orientation and central navigation preference. Egocentric 
orientation requires participants to form an accurate epresentation of the supermarket environment 
during self-motion, and then integrate this representation at the finishing location to produce an 
accurate directional representation of the starting point. ε4 carriers demonstrated significantly more 
difficulty identifying their starting point, suggesting ε4-related problems integrating allocentric-
egocentric frames. Although short-term forgetting could explain this effect, the ε4 group showed no 
impairments on the spatial memory control measures, compared to the non-carrier group (i.e. the VST 
short-term spatial memory task and the four mountains task), making a memory-based causation 
unlikely. The central navigation preference adopted for this study measures the number of allocentric 
location responses in the centre vs the boundary area of the virtual supermarket following path 
integration. This measure then provides a means of dissociating between central vs the boundary 
responses preferences (or biases). The most striking ε4 behavioural discrepancy appeared here, as ε4 
carriers exhibited a strong response biases towards the boundary, compared to non-carriers.  
Behaviourally, the ε4-related bias for reduced central navigation preferences is consistent 
with entorhinal-mediated navigation pattern changes during path integration observed on two other 
experimental navigation tasks (Kunz et al., 2015; please see Hardcastle et al, 2015 for discussion on 
   
border-cell mediated error correction in response to dysfunctional grid-cell activity in the EC). This is 
the first time ε4-related border biases were found following path integration, however, and although 
no neural FC correlate emerged for ε4-related egocentric orientation deficit, reduced FC between the 
right EC - PCC emerged as a significant neural substrate for border preferences in the at-genetic-risk 
group. Right EC – PCC FC also predicted the degree of pisodic memory decline, as reported on the 
CCI (see Contreras et al., 2017 for more information on the CCI).  
To the best of our knowledge, this is the first study to show APOE ε4 carriers with self-
assessed episodic memory and executive function decline also show navigation discrepancies, and 
that border navigation preferences and perceived episodic memory decline are mediated be the 
functional connectivity strength of neural pathways between the EC and PCC. Considering that 
subjective episodic memory decline is believed to be predictive of early Aβ accumulation (Contreras 
et al., 2017; Jessen et al., 2014; Mulder et al., 2010) and co-insides subtle navigation deficits as shown 
here, we conclude that subjective complaints may well contribute to a more sensitive and specific 
diagnosis of preclinical AD, although the relevance of subjective concerns for clinical practice is 
outside the boundaries of this study. 
The role of reduced EC – PCC functional connectivity in preclinical may not be surprising, as 
typically intracellular tau projects from the EC and surrounding areas, to the PCC in the first stages of 
disease (Belloy et al., 2019; Hanseeuw et al., 2019; Jacobs et al., 2018), consistent with animal 
models that show in amyloid positive rodents, tau pthology propagation begins in the EC before 
spreading to the parietal cortex (Ahmed et al., 2014; Khan et al., 2013). This pattern of projection may 
explain the reduced functional connectivity in the at-genetic-risk group, and potentially the impeded 
translation of the allocentric or egocentric coordination system, given that the allocentric system relies 
on entorhinal-hippocampal axis and the egocentric system relies on parietal/PCC regions. In 
opposition of this theory, the egocentric orientation measure did not correlate with the FC strength 
between the EC and PCC or any other ROI-ROI correlates. It may be the that egocentric orientation 
changes are underpinned by functional changes between regions not examined, for example in 
prefrontal lobe areas where extra-cellular deposition of Aβ plaques are also found early in disease 
(Braak and Del Tredici, 2015). This is certainly possible, given the shared variance between 
egocentric orientation and frontal lobe-mediated executive function measured on the CCI, which was 
found here and elsewhere (Moffat et al., 2007).  Finally, increased PCC-precuneus connectivity in the 
genetic-risk group was also found and may be understood in the context of animal models that 
demonstrate moderate levels of Aβ in the brain can enhance FC due to compensatory brain
mechanisms, explaining why increased connectivity strength in intrinsic brain networks is commonly 
found in ε4 cohorts (Badhwar et al., 2017; Chase, 2014; Machulda et al., 2011).  
Despite our results largely supporting and extending current theories of preclinical AD 
models, the study has limitations. Firstly, the sample size fell from sixty-four to thirty-seven when 
investigation the neural correlates of ε4-related navigation impairment which prevents generalization. 
   
We also cannot rule out the possibility that boundary-driven navigation behavioural is caused be 
another neural mechanism and/or the fact that boundary landmarks, although intentionally hidden in 
the VST, may exert an influence toward to border in the ε4 group. Of course, longitudinally tracking 
these participants to confirm whether multimodal frmework presented here is indeed predictive of 
future development of MCI or clinical AD is desired but will take up to a decade to achieve. We thus 
recommend replication of the results in biomarker positive individuals; using flortaucipir and 
Pittsburgh compound B positron emission tomography tracers to assess tau and Aβ pathology, 
respectively. Moreover, as we cannot say if navigation changes precede subjective cognitive deficits 
or vice versa, this ought to be followed up in future investigations. Future studies should also consider 
using a PCC-mediated memory consolidation task in a similar cohort (such as that presented in Bird et 
al., 2015), to examine if this process is compromised in preclinical AD. This will add further insight 
into whether the field should consider PCC-mediated b havioural discrepancies as a marker for 
preclinical AD, as the current focus is primarily on EC-mediated tasks.  
In conclusion, we have shown a distinct association between navigational deficits and altered 
FC in three key nodes of the spatial navigation network. Our results provide important insight into the 
navigational discrepancies sustained by the presenc of ε4 genotype and the underlying 
neurofunctional entities that appear to be consistent with the topographical spread of preclinical 
disease from the EC to the PCC. As recent clinical trials of disease-modifying agents in Alzheimer’s 
disease have failed (Sevigny et al., 2016), the addition of simple multimodal diagnostic models for at-
risk AD should facilitate earlier and targeted intervention to those ‘at-risk’. This would allow 
neuroprotective compounds a higher opportunity of success, with intervention prior to macroscopic 
neuronal loss (Dubois et al., 2014; Reiman et al., 2015). Although further work is required to 
recommend VST as means of enrolling individuals in future clinical trials, the present study aims to 
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Figure 1 | Spatial orientation was assessed using an ecologica  virtual supermarket environment. (A): 
The layout of the virtual environment did not include any notable landmarks. (B): An iPad 9.7 (Apple 
Inc., etc) was used to show participants 7-14-second video clips of a moving shopping trolley. All 
trials began at the same location in the supermarket but followed different routes to reach a different 
end point in each trial. Videos were presented from a first-person perspective and participants were 
taken to a set location while making a series of 90-degree turn. (C): Once the video clip stopped, (D):
   
participants indicate the real-life direction of their starting point. (E): Immediately following, 
participants indicate their finishing location (short-term spatial memory) and heading direction on a 
VST map. (F): Number of place responses made in the center space and boundary spaces were 
recorded. 
 
Figure 2 | (A): The effect of genotype on short-term spatial memory, (B): egocentric orientation and 
(C) central navigation preference. 
 
Figure 3 | (A): APOE-dependent correlations in functional connectivity between selected ROIs: 
right/left hippocampus, right/left EC, PCC, Precuneus. (B): The 6node × 6node network matrix of 
correlation coefficients represents connectivity strength between nodal pairs in a dual regression to 
test two-group subject difference on subject specific nodal pair connectivity. Right EC and PCC 
connectivity was significantly lower in the ε3ε4 group than in the ε3ε3 group. Trend differences in the 
opposite direction were observed between the precuneus and the PCC, with higher functional 
connectivity between these regions the ε3ε4 group than in the ε3ε3 group. (C): Significant association 
between the right entorhinal and posterior cingulate cortices connectivity and i) central navigation 
preference ii) cognitive change index – episodic memory but not iii) cognitive change index – 
executive function. 
 
Figure 4 | Logistic regression and ROC curves for right EC– PCC functional connectivity strength 
(green line) and VST cognitive measures central preference (blue) and egocentric orientation (red) 
predicting variants of the APOE genotype. (A):  Logistic regression indicated that the regression 
model based on function connectivity and VST cognitive predictors was statistically significant. (B): 
Area under the curve (AUC) values indicated EC-PCC and egocentric orientation had a similar level 




Table 1 Primary demographic and neuropsychological profile 
    
 ε3ε3 carrier (n=32) ε3ε4 carrier (n=32) P value 
Age (years)     
 Mean (SD) 62.24 (5.32) 62.19 (5.58) - 
Sex     
 Male 17 22 - 
 Female 15 10 - 
ACE 94.47 (3.83) 
 
92.88 (3.78) .12 (F=2.49) 
FMT 10.22 (2.91) 
 













Primary demographic and neuropsychological characteristics of the genetic groups (Independent sample t-test, 
two-tailed). ACE= Addenbrooke’s cognitive examination. FMT = Four mountains test. ROCT = The Rey–
Osterrieth complex figure. Recall administered three minutes after copy. 
 
 
Table 2 Effect of genotype on the VST spatial orientation paradigm 
 Mean (SD) F P value 
Egocentric orientation    
ε3ε3 12.01 (2.3) 4.21 .042 
ε3ε4 10.94 (3.7)   
Heading direction     
ε3ε3 11.92 (2.7) .799 .375 
ε3ε4 11.31 (3.0)   
Spatial memory    
ε3ε3 7.43 (2.7) .014 .907 
ε3ε4 7.34 (3.0)   
Central vs boundary 
preference 
   
ε3ε3 .57 (.21) 12.45 < 0.005 
ε3ε4 .38 (.14)   
ANCOVA with age and sex as covariates testing the diff rence of egocentric orientation, heading orientation, 







• Navigation deficits differentiate high-risk and low-risk AD groups  
• Navigation deficits onset approximately the same time as subjective concerns  
• Connectivity between the EC and the PCC underpins the phenotype of the high-risk group 
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